* Clover Health Investments Corp CLOV.OQ CLOV.O is
expected
to show a fall in quarterly revenue when it reports results on
August 8.
* The Franklin Tennessee-based company is expected to
report a
42.0% decrease in revenue to $490.821 million from $846.7
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Clover Health
Investments
Corp is for a loss of 15 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Clover
Health
Investments Corp is $1.13, below its last closing price
of $1.35.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 -0.17 -0.18 -0.15 Beat 14.7
Dec. 31 2023 -0.23 -0.26 -0.17 Beat 31.4
Sep. 30 2022 -0.25 -0.24 -0.16 Beat 33.1
Jun. 30 2022 -0.21 -0.21 -0.22 Missed -6.7
Mar. -0.28 -0.27 -0.19 Beat 30.5
31 2022
Dec. 31 2021 -0.27 -0.26 -0.28 Missed -7.9
Sep. 30 2021 -0.24 -0.23 -0.08 Beat 65
Jun. 30 2021 -0.13 -0.14 -0.78 Missed -476.4
This summary was machine generated August 4 at 21:02 GMT. All
figures in US dollars unless otherwise stated